OPTIC: Opioid Policy Tools and Information Center | View in browser

Twitter Facebook

RAND-USC Schaeffer OPTIC

A National Resource for Opioid Policy Science

RAND Corporation logo

Note from the Director

Bradley Stein

We are pleased to announce the release of our first wave of OPTIC-vetted policy data sets, intended to help researchers and the policy community understand some of the different ways particular policy variables have been defined and provide a useful resource for checking the importance and sensitivity of alternative definitions in their own work. This should improve awareness of these issues and promote reproducibility of study findings. For example, prescription drug monitoring programs (PDMPs) might look identical, but how the programs function can differ by state. Our OPTIC-vetted policy data sets showcase important alternative definitions researchers have used for PDMPs and other opioid-related policies. The data sets and documentation are available for public use and can be downloaded as .zip files from OPTIC's site.

We also posted the OPTIC Policy Center Literature Library, which includes peer-reviewed articles published between 2005 and 2018 that are summarized in a recent paper. The library can be searched by keyword, type of policy, and/or type of outcome.

Finally, in mid-September we offered a webinar: Pitfalls and Potholes: Issues to Consider When Conducting Analyses of State Opioid Policy. Presented by Rosalie Pacula and Rosanna Smart, the webinar focused on data dimensions that researchers should keep in mind when seeking to draw conclusions from studies, including the policy definitions data curators are using and which attributes of a policy are being evaluated from study to study. We have also added a list of COVID-19 related resources to our site, drawing from work across the scientific community.

Stay safe. – Bradley Stein, Director OPTIC

Recent Products from OPTIC Researchers

Multi-layered and multi-colored graphing of data, photo by monsitj/Getty Images

Photo by monsitj/Getty Images

Pitfalls and Potholes: Data Issues to Consider When Analyzing State Opioid Policies

This OPTIC webinar presents the data dimensions to keep in mind when analyzing state opioid policies. Read more »

Open laptop in front of a stack of books, photo by Nutthaseth Vanchaichana/Getty Images

Photo by Nutthaseth Vanchaichana/Getty Images

The State of the Science in Opioid Policy Research

The rigor of study design varies notably across policy categories, highlighting the need for broader adoption of rigorous methods in opioid policy research. Read more »

Naloxone Kit distributed by healthcare professionals to users to help combat opioid crisis in case of overdose, photo by NewGig86/Getty Images

Photo by NewGig86/Getty Images

Systematic Review of the Emerging Literature on the Effectiveness of Naloxone Access Laws in the United States

The existing literature on naloxone access laws in the United States supports beneficial effects for increased naloxone distribution, but provides inconclusive evidence for reduced fatal opioid overdose.
Read more »
Search the Literature Library Tool »

Closeup of a doctor tearing a prescription off a pad, photo by wdstock/Getty Images

Photo by wdstock/Getty Images

How Increasing Medical Access to Opioids Contributes to the Opioid Epidemic: Evidence from Medicare Part D

The national growth in opioid supply explains 75% of the national rise in opioid treatment admissions and the diversion component is a critical driver of the opioid epidemic. Read more »

Hand holding a pill, with pills and a prescription bottle in the background, photo by stevehullphotography/Getty Images

Photo by stevehullphotography/Getty Images

Variation in the Degree of Concentration of Prescription Opioid Utilization Using Different Measures

A small share of prescription opioid users account for a large percent of total prescription opioid use. Read more »

Close up of a pregnant woman in a hospital gown laying down, photo by FatCamera/Getty Images

Photo by FatCamera/Getty Images

Association of Pregnancy and Insurance Status With Treatment Access for Opioid Use Disorder

In this cross-sectional study with random assignment of clinicians and simulated-patient callers, many women, especially pregnant women, faced barriers to accessing quality opioid use disorder treatment. Read more »

View All Publications »

Commentary and Press

Pregnant Women Have a Harder Time Getting Treatment for Opioid Use Disorder, New Study Finds (Vanderbilt University)

Truth Decay, Opioid Settlement Funds, Veterans Health Care: RAND Weekly Recap (RAND Corp.)

Opioid Scandal Haunts Drug Companies As They Respond To Pandemic (NPR)

75%

of the increase in opioid treatment admissions is explained by growth in opioid supply.

(RAND Corporation)

National Perspectives

A national sampling of thought-provoking research and insights

The Importance of Data Source in Prescription Drug Monitoring Program Research - Horwitz JR et al. Health Serv Res

Primary Care Providers And Specialists Deliver Comparable Buprenorphine Treatment Quality - Gertner AK et al. Health Aff

Medication for Opioid Use Disorder: A National Survey of Primary Care Physicians - McGinty EE et al. Ann Intern Med

Adoption of Telemedicine Services by Substance Abuse Treatment Facilities in the U.S. - Uscher-Pines L et al. J Subst Abuse Treat

Prescription Opioid Dispensing Patterns Prior to Heroin Overdose in a State Medicaid Program: A Case-Control Study - Hartung DM et al. J Gen Intern Med

Therapies Offered at Residential Addiction Treatment Programs in the United States - Beetham T et al. JAMA

Situating the Continuum of Overdose Risk in the Social Determinants of Health: A New Conceptual Framework - Park JN et al. Milbank Q

Association of State-Level Opioid-Reduction Policies With Pediatric Opioid Poisoning - Toce MS et al. JAMA Pediatr

African Americans Now Outpace Whites in Opioid-Involved Overdose Deaths: a Comparison of Temporal Trends from 1999 to 2018 - Furr-Holden D et al. Addiction

Association of Treatment With Medications for Opioid Use Disorder With Mortality After Hospitalization for Injection Drug Use-Associated Infective Endocarditis - Kimmel SD et al. JAMA Netw Open

Treatment Of Opioid Use Disorder Among Commercially Insured U.S. Adults, 2008-17 - Shen K, Barrette E, Dafny LS. Health Aff

Telehealth for Substance-Using Populations in the Age of Coronavirus Disease 2019: Recommendations to Enhance Adoption - Lin LA, Fernandez AC, Bonar EE. JAMA Psychiatry

Medication Treatment for Opioid Use Disorder and Community Pharmacy: Expanding Care During a National Epidemic and Global Pandemic - Cochran G et al. Subst Abus

Forthcoming Presentations

November 16, 2020
Presenting a data workshop on "Data issues to consider when conducting analysis of state opioid policies" at Addiction Health Services Research (AHSR) Conference - Rosalie L. Pacula, Rosanna Smart

December 14, 2020
Presenting a Methods workshop on "State-level opioid policy analyses: moving beyond the classic difference-in-difference model" at Addiction Health Services Research (AHSR) Conference - Megan Schuler, Beth Ann Griffin

Leadership

Brad Stein

Bradley Stein

Director

Rosalie Liccardo Pacula

Rosalie Liccardo Pacula

Codirector

Beth Ann Griffin

Beth Ann Griffin

Codirector

 

OPTIC is designed to be a national resource, fostering innovative and high-quality research in opioid policy science, and developing and disseminating methods, tools, and information to the research community, policymakers, and other stakeholders.

http://www.rand.org/OPTIC

Follow RAND

Twitter Facebook LinkedIn Instagram

Privacy statement

RAND Corporation

RAND Corporation. 1776 Main Street, Santa Monica, CA 90401-3208.
RAND® is a registered trademark.